Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitors.
An L, Wang Y, Wu G, Wang Z, Shi Z, Liu C, Wang C, Yi M, Niu C, Duan S, Li X, Tang W, Wu K, Chen S, Xu H.
An L, et al.
Transl Res. 2023 May;255:14-25. doi: 10.1016/j.trsl.2022.11.002. Epub 2022 Nov 5.
Transl Res. 2023.
PMID: 36347492
Free article.